Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-02 Roivant Sciences Ltd. Director Grant or award +4,473,684 $38.00 $170.0M 78,279,015
2023-10-02 Roivant Sciences Ltd. Director Purchase +1,526,316 $38.00 $58.0M 79,805,331
2023-08-30 Salzmann Peter Chief Executive Officer Sale −50,866 $21.97 $1.1M 975,873
2023-08-30 Salzmann Peter Chief Executive Officer Sale −5,908 $22.48 $133K 969,965
2023-08-24 Levine Mark S. Chief Legal Officer Sale −12,285 $20.30 $249K 314,489
2023-08-24 Levine Mark S. Chief Legal Officer Sale −1 $20.89 $21 314,488
2023-08-24 Barnett Eva Renee Chief Financial Officer Sale −14,385 $20.30 $292K 335,478
2023-08-24 Barnett Eva Renee Chief Financial Officer Sale −1 $20.89 $21 335,477
2023-08-24 Butchko Julia G. Chief Development Officer Sale −12,332 $20.30 $250K 416,261
2023-08-24 Butchko Julia G. Chief Development Officer Sale −1 $20.89 $21 416,260
2023-08-24 Macias William L. Chief Medical Officer Sale −12,332 $20.30 $250K 337,393
2023-08-24 Macias William L. Chief Medical Officer Sale −1 $20.89 $21 337,392
2023-08-14 Salzmann Peter Chief Executive Officer Sale −91,744 $21.34 $2.0M 1,038,053
2023-08-14 Salzmann Peter Chief Executive Officer Sale −11,314 $22.04 $249K 1,026,739
2023-08-07 Salzmann Peter Chief Executive Officer Sale −101,339 $21.73 $2.2M 1,129,797
2023-07-26 Levine Mark S. Chief Legal Officer Sale −3,917 $21.63 $85K 326,774
2023-07-19 Macias William L. Chief Medical Officer Sale −426 $24.94 $11K 349,725
2023-07-19 Barnett Eva Renee Chief Financial Officer Sale −2,725 $24.94 $68K 349,863
2023-07-12 Salzmann Peter Chief Executive Officer Sale −3,233 $19.73 $64K 1,231,136
2023-07-12 Butchko Julia G. Chief Development Officer Sale −1,470 $19.73 $29K 428,593

Page 17 of 18 · 351 trades